Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02393599Phase 1Completed
Phase 1, randomised, double-blind trial in cocaine use disorder (CUD) comparing Lorcaserin with Placebo (2 arms). Primary endpoints: Number of Participants with Adverse Events and Number of Participants with Cardiovascular Responses. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02393599.